Vontobel Holding Ltd. Seres Therapeutics, Inc. Transaction History
Vontobel Holding Ltd.
- $27.3 Billion
- Q4 2024
A detailed history of Vontobel Holding Ltd. transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 938,295 shares of MCRB stock, worth $788,167. This represents 0.0% of its overall portfolio holdings.
Number of Shares
938,295
Previous 394,826
137.65%
Holding current value
$788,167
Previous $375,000
107.47%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding MCRB
# of Institutions
80Shares Held
41.1MCall Options Held
304KPut Options Held
471K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$19.4 Million3.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.06MShares$5.09 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$1.48 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.39MShares$1.17 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.19MShares$1 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $104M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...